Key statistics
On Saturday, Novocure Ltd (N2VC34:SAO) closed at 5.94, 14.67% above the 52 week low of 5.18 set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.94 |
|---|---|
| High | 5.94 |
| Low | 5.94 |
| Bid | 5.01 |
| Offer | 8.60 |
| Previous close | 5.60 |
| Average volume | 635.50 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 14 2026 00:45 GMT.
More ▼
Press releases
- U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
- Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
- Novocure Appoints Company President Frank Leonard as Chief Executive Officer
- Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
More ▼
